Advances in Ovarian Cancer Diagnostics: The Role of ROMA, CA 125 and HE4
AI, Data Science & Cloud Certificates from Google, IBM & Meta
Future-Proof Your Career: AI Manager Masterclass
Overview
Build a Learning Habit
Download Class Central's free printable study calendar
Download for Free
This 53-minute webinar presented by Dr. Joel Cardenas, a board-certified gynecologic oncologist, explores the latest advances in ovarian cancer diagnostics with a focus on the Risk of Ovarian Malignancy Algorithm (ROMA) and biomarkers CA125 and HE4. Gain an in-depth understanding of the current ovarian cancer landscape, including epidemiological data and survival rates, while learning about the limitations of traditional diagnostic methods. Discover how to leverage these advanced diagnostic tools to improve early detection, which remains crucial as ovarian cancer often presents at late stages with poor prognosis. Dr. Cardenas brings extensive expertise in minimally invasive surgical approaches and gynecologic oncology, having trained at prestigious institutions including the University of Pennsylvania Health System and Mount Sinai. By the end of this educational session, understand how to effectively integrate CA125, HE4, and the ROMA algorithm into clinical practice to improve diagnostic accuracy and ultimately enhance patient outcomes.
Syllabus
Advances in Ovarian cancer diagnostics: The role of ROMA, CA 125 and HE4
Taught by
Labroots